Your Cart

Cart

Worldwide Secure Delivery - Simple, Secure & Convenient Healthcare Solutions - Regulation Compliant Medications
Menu
Conditions
Worldwide Secure Delivery - Simple, Secure & Convenient Healthcare Solutions - Regulation Compliant Medications

HomePharmaHubCancerLung CancerTagrisso (osimertinib mesylate)

Rx

Tagrisso (osimertinib mesylate)

Brand: Tagrisso
Active Ingredient(s): osimertinib mesylate
Pack Size: 30 – 30 – 28 – 28 Tablets
Store at room temperature.
DIN:
Manufacturer: AstraZeneca AB (EU)
Alternatives:

Ask for a Price

*A valid prescription is required for Rx items.

Add to wishlist
Ask about product
Treatments: ,

Description

Tagrisso (Osimertinib Mesylate) is an anticancer agent. It is typically used to treat non-small cell lung cancer (NSCLC) in adults who have a specific genetic mutation in their tumor. It works by blocking the activity of abnormal proteins that cause the cancer cells to grow and spread. This helps slow down the growth of the cancer and can improve symptoms such as shortness of breath or coughing. It may also have other uses.

Additional information

Tagrisso (Osimertinib Mesylate) is usually taken once daily. However, your doctor or pharmacist may suggest a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not take more of this product, or take it more often, than prescribed. If you miss a dose, contact your pharmacist. It can be taken with or without food.

WARNING: This medication can cause inflamed or scarred lungs and death in some cases. Abnormal electrical signal of the heart can happen, as well as heart problems such as when your heart is weak and can’t pump well enough to get blood to the body. It may lead to death.

In addition to its desired effect, this medication may cause some side effects, notably:

It may cause back pain, changes in eyesight, cough
It may cause decrease in appetite, sores inside the mouth, hair loss, headache

Contraindications: Do not use this medication if you have a known allergy (hypersensitivity) to any of its ingredients.

Taking this medication during pregnancy is contraindicated and harmful for the baby. Women of childbearing potential should use an effective contraceptive method. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor.

A treatment with this medication requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.

Warning

Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.

Reviews

Be the first to review “Tagrisso (osimertinib mesylate)”

Your email address will not be published. Required fields are marked *

There are no reviews yet.